Results
- Showing results for:
- Reset all filters
Search results
-
Journal articleThielmann F, Burnett D, Bismarck A, 2005,
Measuring adhesion phenomena between carbon fibers and model polymer matrices
, International SAMPE Symposium and Exhibition Proceedings, Vol: 50, Pages: 1551-1558, ISSN: 0891-0138The interaction between carbon fibers with different surface treatments and thermoplastic polymer matrices were investigated through thermodynamic, work of adhesion calculations and mechanical, practical adhesion measurements. The works of adhesion between carbon fiber and polymer were done by measuring the dispersive and specific surface energetics of the individual components using Inverse Gas Chromatography (IGC). The mechanical adhesion measurements were performed by measuring the interfacial shear stress of the carbon fiber imbedded into the polymer through single fiber pull-out testing. The PAN-based carbon fibers under investigation were an untreated (CA), an oxidized (AS4) and an oxidized and epoxy-sized (AS4-GP) material. The polymer matrices studied were polycarbonate, polysulfone, and polyetherimide. The IGC surface energy experiments revealed a much higher dispersive surface energy for the AS4 sample compared to the CA sample, indicating that oxidation creates a more active surface. The sized, AS4-GP, sample had the lowest dispersive surface energy due to the passivation of the surface from the epoxy-based sizing agent. Specific interactions showed a decrease in the basicity from the untreated to oxidized samples, while the acidity increases. Works of adhesion calculated from the surface energetics correlated well with the interfacial shear stress values. For all three polymers there was an increase in both the work of adhesion and shear strength values by oxidizing the carbon fiber. The sizing material does not significantly increase the shear strength despite a higher work of adhesion value, which may be caused by the polymers and epoxy-based sizing agent not being compatible.
-
Conference paperHafler DA, Rao A, Goodnow CC, et al., 2005,
Discussion
, Pages: 192-199, ISSN: 1528-2511 -
Journal articleAziz ZA, Wells AU, Desai SR, et al., 2005,
Functional impairment in emphysema: Contribution of airway abnormalities and distribution of parenchymal disease
, AMERICAN JOURNAL OF ROENTGENOLOGY, Vol: 185, Pages: 1509-1515, ISSN: 0361-803X- Cite
- Citations: 79
-
Journal articleSafinia L, Datan N, Höhse M, et al., 2005,
Towards a methodology for the effective surface modification of porous polymer scaffolds
, BIOMATERIALS, Vol: 26, Pages: 7537-7547, ISSN: 0142-9612- Cite
- Citations: 82
-
Journal articleHollax EJ, Davies J, Griesenbach U, et al., 2005,
Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis
, J Negat Results Biomed, Vol: 7 -
Journal articleHilliard T, Edwards S, Buchdahl R, et al., 2005,
Voriconazole therapy in children with cystic fibrosis.
, J Cyst Fibros, Vol: 4, Pages: 215-220, ISSN: 1569-1993BACKGROUND: There is increasing evidence for the efficacy of the antifungal voriconazole, particularly in immunosuppression. We describe our experience of using voriconazole in children with CF. METHODS: We performed a retrospective case note review of children with CF treated with voriconazole in a single centre over an 18 month period. RESULTS: A total of 21 children aged 5 to 16 years (median 11.3) received voriconazole for between 1 and 50 (22) weeks. Voriconazole was used as monotherapy in 2 children with recurrent allergic bronchopulmonary aspergillosis (ABPA); significant and sustained improvements in clinical and serological parameters for up to 13 months were observed, without recourse to oral steroids. Voriconazole was used in combination with an immunomodulatory agent in a further 11 children with ABPA, with significant improvement in pulmonary function and serology. 8 children without ABPA but who had recurrent Aspergillus fumigatus isolates and increased symptoms also received voriconazole; this group did not improve with treatment. Adverse effects occurred in 7 children (33%: photosensitivity reaction 3, nausea 2, rise in hepatic enzymes 1, hair loss 1). CONCLUSIONS: Voriconazole may be a useful adjunctive therapy for ABPA in CF. Voriconazole monotherapy appears to be an alternative treatment strategy when oral corticosteroids may not be suitable.
-
Journal articleAdcock IM, Ito K, Barnes PJ, 2005,
Histone deacetylation: an important mechanism in inflammatory lung diseases.
, COPD, Vol: 2, Pages: 445-455, ISSN: 1541-2555Inflammatory lung diseases are characterised by increased expression of multiple inflammatory genes that are regulated by proinflammatory transcription factors, such as NF-kappaB. Gene expression is regulated by modifications such as acetylation of core histones through the concerted action of coactivators such as CBP (cAMP-response element binding protein (CREB)-binding protein) which have intrinsic histone acetyltransferase (HAT) activity and are able to recruit other HAT enzymes. Conversely gene repression is mediated via histone deacetylases (HDAC) and other corepressors. In biopsies from asthmatic subjects there is an increase in HAT activity and some reduction in HDAC activity. Both of these changes are partially reversed by corticosteroid therapy. Corticosteroids switch off inflammatory genes in asthma through a combination of a direct inhibition of HAT activity and by the recruitment of HDAC2 to the activated NF-kappaB-stimulated inflammatory gene complex. In chronic obstructive pulmonary disease (COPD), a corticosteroid insensitive disease, there is a reduction in HDAC activity and HDAC2 expression, which may account for the amplified inflammation and resistance to the actions of corticosteroids. The reduction in HDAC2 may be secondary to oxidative and nitrative stress as a result of cigarette smoking and severe inflammation. This may also occur to differing degrees in severe asthma, smoking asthmatic patients and cystic fibrosis. Similar mechanisms may also account for the steroid resistance seen within latent adenovirus infections. The reduction in HDAC activity induced by oxidative stress can be restored by theophylline, acting through specific kinases, which may be able to reverse steroid resistance in COPD and other inflammatory lung diseases. The modulation of HAT/HDAC activity may lead to the development of novel anti-inflammatory approaches to inflammatory lung diseases that are currently difficult to treat.
-
Journal articleSaouros S, Edwards-Jones B, Reiss M, et al., 2005,
A novel galectin-like domain from <i>Toxoplasma gondii</i> micronemal protein 1 assists the folding, assembly, and transport of a cell adhesion complex
, JOURNAL OF BIOLOGICAL CHEMISTRY, Vol: 280, Pages: 38583-38591- Cite
- Citations: 63
-
Journal articleRicciardolo FLM, Caramori G, Ito K, et al., 2005,
Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease
, JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, Vol: 116, Pages: 1028-1035, ISSN: 0091-6749- Cite
- Citations: 116
-
Journal articleWalters MJ, Paul-Clark MJ, McMaster SK, et al., 2005,
Cigarette smoke activates human monocytes by an oxidant-AP-1 signaling pathway: Implications for steroid resistance
, MOLECULAR PHARMACOLOGY, Vol: 68, Pages: 1343-1353, ISSN: 0026-895X- Cite
- Citations: 76
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.
General enquiries
For any enquiries about the Fungal Science Network at Imperial, please contact: